![Clinical Trial Landscape: Non-small Cell Lung Cancer (NSCLC)](https://www.precisionformedicine.com/hs-fs/hubfs/PFM%20-%202024%20New%20blog%20images/Cancer%20poumon%20non%20%C3%A0%20petites%20cellules.webp?width=396&height=224&name=Cancer%20poumon%20non%20%C3%A0%20petites%20cellules.webp)
![Ibrahim, Bello Avatar](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/PfMxMarkentive/authors/ibrahim-bello.webp?width=100&height=100&name=ibrahim-bello.webp)
Ibrahim Bello
Ibrahim Bello, BSc (Hons) is a senior project director at Precision for Medicine with 25+ years’ experience within the global pharmaceutical development environment in CRO, biotech, and pharma, covering project management, study management and data management. He has a keen interest in cutting edge trial designs and a passion for successful collaborations.
-
Read: Clinical Trial Landscape: Non-small Cell Lung Cancer (NSCLC) Clinical Trial Landscape: Non-small Cell Lung Cancer (NSCLC)